| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |